Abstract


Objective: Varicella is common in childhood in countries where a routine vaccination program is not implemented. The disease can cause serious morbidity and even mortality, especially with increasing age. In our country, the varicella vaccine was included in the national vaccination program on 1 January 2013. The aim of this study was to investigate the hospitalized children with varicella after the administration of varicella vaccine in the national vaccination program. 

Material and Methods: Pediatric patients who were admitted to our tertiary research hospital between January 1, 2012 and December 31, 2017 with a diagnosis of varicella were evaluated retrospectively. The patient demographics, clinical characteristics, underlying diseases, duration of hospitalization, hospitalization costs, and complications were analyzed. 

Results: A total of 104 cases consisting of 66 (63.5%) males and 38 (36.5%) females were included. Of these cases, 40 (38.4%) were aged under 24 months, 36 (34.6%) between 25 and 72 months, and 28 (27%) over 73 months. There were no underlying diseases in 45 (43.3%) cases. The causes of admission were pulmonary infection in 21 (20.2% ) cases, bacterial skin superinfections in 21 (20.2%) cases, cerebellitis in 7 (6.7%) cases, disseminated rash in 6 (5.8%) cases, hepatitis in 4 (3.8%) cases, febrile convulsions in 4 (3.8%) cases, severe thrombocytopenia in 3 (2.9%) cases, meningoencephalitis in 3 (2.9%) cases, and bronchiolitis in 1(1%) case of all admissions, 24% were in 2012, 10.6% in 2016, and 5.8% in 2017. The median hospital cost per hospital stay was not different in patients without an underlying disease compared to patients with an underlying disease. The median duration of hospitalization was 7 (3-42) days in patients without an underlying disease. 

Conclusion: These findings indicate that chickenpox can cause a serious problem even in healthy children without underlying diseases. Following the inclusion of varicella vaccine in the national vaccination program, a critical decrease was observed in the frequency of cases requiring hospitalization. 







Keywords: Complication, Varicella, Vaccination

References

  1. 1. Heininger U, Seward JF. Varicella. Lancet 2006;368:1365-76.
  2. 2. Centers for Disease Control and Prevention. Varicella. In Hamborsky
  3. J, Kroger A, Wolfe S (eds). Epidemiology and Prevention of Vaccine-
  4. Preventable Diseases. The Pink Book: Course Textbook, 13th ed,
  5. Washington, DC: Public Health Foundation, 2015. http://www.cdc.
  6. gov/vaccines/pubs/pinkbook/index.html (Accessed on Apr, 2018).
  7. 3. American Academy of Pediatrics. Varicella-zoster virus infections.
  8. In: Kimberlin DW, Brady MT, Jackson MA, Long SS (eds). RedBook.
  9. 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk
  10. Grove Village: IL 2015:846-56.
  11. 4. Dinleyici EC, Kurugol, Z, Turel O, Hatipoglu N, Devrim I, Agin, H,
  12. et al. The epidemiology and economic impact of varicella-related
  13. hospitalizations in Turkey from 2008 to 2010: A nation wide survey
  14. during the pre-vaccine era (VARICOMP study). Eur J Pediatr
  15. 2012;171:817-25.
  16. 5. Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola
  17. L, et al. Varicella in infants after implementation of the US varicella
  18. vaccination program. Pediatrics 2011;128:1071-7.
  19. 6. Tan B, Bettinger J, McConnell A, Scheifele D, Halperin S, Vaudry W,
  20. et al; Members of the Canadian Immunization Monitoring Program,
  21. Active (IMPACT). The effect of funded varicella immunization
  22. programs on varicella-related hospitalizations in IMPACT centers,
  23. Canada, 2000–2008. Pediatr Infect Dis J 2012;31:956–63.
  24. 7. Siedler A, Arndt U. Impact of the routine varicella vaccination
  25. programme on varicella epidemiology in Germany. Euro Surveill
  26. 2010;15(13):pii19530.
  27. 8. Pezzotti P, Bellino S, Prestinaci F, Iacchini S, Lucaroni F, Camoni
  28. L, et al. The impact of immunization programs on 10 vaccine
  29. preventable diseases in Italy: 1900–2015. Vaccine 2018;11:1435-
  30. 48.
  31. 9. Garcia Cenoz M, Castilla J, Chamorro J, Martinez-Baz I, Martinez
  32. Artola V, Irisarri F, et al. Impact of universal two-dose vaccination
  33. on varicella epidemiology in Navarre, Spain, 2006 to 2012. Euro
  34. Surveill 2013;18:20552.
  35. 10. Heywood AE, Wang H, Macartney KK, McIntyre P. Varicella and
  36. herpes zoster hospitalizations before and after implementation of
  37. one-dose varicella vaccination in Australia: An ecological study.
  38. Bull World Health Organ 2014;92:593–604.
  39. 11. Straus SE, Ostrove JM, Inchauspé G, Felser JM, Freifeld A, Croen
  40. KD et al: NIH conference. Varicella-zoster virus infections. Biology,
  41. natural history, treatment, and prevention. Ann Intern Med 1988;
  42. 108:221-37.
  43. 12. Pnomoni tanı ve tedavi uzlaşı raporu 2009. Türk Toraks Derneği.
  44. 13. Vankatesan A, Tunkel AR, Bluch KC, Lauring AS, Sejyar J, Bitnun
  45. A, et al. Case definitions, diagnostic algorithms and priorities in
  46. encephalitis: Consensus statement of the international encephalitis
  47. consortium. Clin Infect Dis 2013;57:1114-28.
  48. 14. Bozzola E, Tozzi AE, Bozzola M, Krzysztofiak A, Valentini D, Grandin
  49. A, et al. Neurological complications of varicella in childhood:
  50. Case series and a systematic review of the literature. Vaccine
  51. 2012;30:5785–90.
  52. 15. Felek S. Karaciğer ve safra yolları infeksiyonları. İçinde: Sistemik
  53. İnfeksiyon Hastalıkları. 1. baskı, İstanbul: Nobel Tıp Kitabevi,
  54. 2000:195-212.
  55. 16. Lusher JM. Clinical and laboratory approach to the patient with
  56. bleeding. In: Nathan DG, Orkin SH, Ginsburg D, Look AT (eds).
  57. Nathan and Oski’s Hematology of Infancy and Childhood. 6th ed.
  58. Philadelphia: Saunders, 2003:1515-20.
  59. 17. Koturoglu G, Kurugöl Z, Cetin N, Hizarcioglu M, Vardar F, Helvaci
  60. M, et al. Complications of varicella in healthy children in Izmir,
  61. Turkey. Pediatr Int 2005;47:296-99.
  62. 18. Ozdemir H, Candir, MO, Karbuz A, Belet N, Tapisiz A, Ciftci E, et
  63. al. Chickenpox complications, incidence and financial burden in
  64. previously healthy children and those with an underlying disease in
  65. Ankara in the pre-vaccination period. Turk J Pediatr 2011;53:614-
  66. 25.
  67. 19. Bonsignori F, Chiappini E, Frenos S, Peraldo M, Galli L, de Martino
  68. M. Hospitalization rates for complicated and uncomplicated
  69. chickenpox in a poorly vaccinated pediatric population. Infection
  70. 2007;35:444–50.
  71. 20. Theodoridou M, Laina I, Hadjichristodoulou C, Syriopoulou V.
  72. Varicella-related complications and hospitalisations in a tertiary
  73. pediatric medical center before vaccine introduction. Eur J Pediatr
  74. 2006;165:273–74.
  75. 21. Sauerbrei A. Review of varicella-zoster virus infections in pregnant
  76. women and neonates. Health 2010;2:143-52.
  77. 22. Freij BJ, Sever JL. Viral and protozoal infections. In: Mhairi MG,
  78. Mullett MD, Seshia MM (eds). Avery’s Neonatology: Pathophysiology
  79. and Management of the Newborn. 6th ed. Philadelphia: Lippincott
  80. Williams Wilkins, 2005:1274-356.
  81. 23. Centers for Disease Control and Prevention (CDC). A new product
  82. (VariZIG) for postexposure prophylaxis of varicella available under
  83. an investigational new drug application expanded access protocol.
  84. MMWR Morb Mortal Wkly Rep 2006;55:209-10.
  85. 24. Gershon AA. Chickenpox, measles, and mumps. In: Remington
  86. JS, Klein JO, Wilson CB, Nizet V, Maldonado YA (eds). Infectious
  87. Disease of the Fetus and Newborn Infant. 7th ed. Philadelphia:
  88. Elsevier Saunders, 2011:899-904.
  89. 25. Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH,
  90. Kries R, et al. The burden of varicella complications before the
  91. introduction of routine varicella vaccination in Germany. Pediatr
  92. Infect Dis J 2008;27:119–24.
  93. 26. Marchetto S, de Benedictis FM, de Martino M, Versace A,
  94. Chiappini E, Bertaine C, et al. Epidemiology of hospital admissions
  95. for chickenpox in children: An Italian multicentre study in the prevaccine
  96. era. Acta Paediatr 2007;96:1490–93.
  97. 27. Bonhoeffer J, Baer G, Muehleisen B, Aebi C, Nadal D, Schaad UB,
  98. et al. Prospective surveillance of hospitalisations associated with
  99. varicella-zoster virus infections in children and adolescents. Eur J
  100. Pediatr 2005;164:366–70.
  101. 28. Kulcu N, Say A,Guven F, Sezer RG, Degirmenci S, Sahin E. Bir
  102. eğitim hastanesinde suçiçeği ve komplikasyonları sebebiyle yatırılan
  103. hastaların değerlendirilmesi. J Pediatr Inf 2012;6:12-7.
  104. 29. Davis MM, Patel MS, Gebremariam A. Decline in varicella related
  105. hospitalizations and expenditures for children and adults after
  106. introduction of varicella vaccine in the United States. Pediatrics
  107. 2004;114:786-92.
  108. 30. Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related
  109. hospitalizations in the United States, 2000-2006: The 1-dose
  110. varicella vaccination era. Pediatrics 2011;127:238-45.

Copyright and license

How to cite

1.
Haytoğlu Z. Evaluation of Hospitalizations among Children with Varicella Between 2012 and 2017 at an University Hospital. Turk J Pediatr Dis [Internet]. 2020 Mar. 18 [cited 2025 May 26];14(2):102-7. Available from: https://turkjpediatrdis.org/article/view/699